Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which therapy unfreezes shoulders faster? new study pits mulligan vs maitland

NCT ID NCT06927115

Symptom relief Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two common physiotherapy techniques—Mulligan and Maitland mobilizations—in 42 adults aged 35-50 with frozen shoulder (adhesive capsulitis). The goal was to see which method better reduces pain, improves shoulder movement, and enhances daily function and quality of life. Participants received one of the two treatments, and outcomes were measured using pain scales, range of motion, and shoulder disability questionnaires.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Apr 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 35-50 years. * Diagnosed case of primary adhesive capsulitis. * Pain and limited range of motion in the affected shoulder. (External rotation\>abduction\>internal rotation) * Willing to participate in the study Exclusion Criteria: * Previous shoulder surgery. * Severe osteoporosis or fractures. * Neurological or rheumatological conditions. * Neck and cardiac surgery * History of recent fractures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adhesive capsulitis of shoulder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bursitis frozen shoulder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adhesive capsulitis of shoulder

Contacts and locations

Locations

  • Riphah international University Malakand Campus

    Chakdara, KPK, 18800, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.